FOLFIRINOX is an acronym for a group of chemotherapy schemes approved in oncology and used for treating pancreatic cancer.
The classical scheme FOLFIRINOX consists of:
This scheme appeared in 2010 as a new treatment method for patients with metastatic pancreatic cancer. One research published in NEJM (New England Journal of Medicine) showed that the FOLFIRINOX regimen demonstrated the most significant increase of longevity among patients with advanced stages of pancreatic cancer (among all Phase III clinical trials studying this pathology). Patients, who get FOLFIRINOX regimen lived on average 4 months longer than patients with standard monotherapy with Gemcitabine (11.1 month in comparison with 6.8 months).
Onco.Rehab clinic uses a lot of effective schemes FOLFIRINOX, also in combination with curcumin, to achieve best results in cancer treatment.
To get a consultation/hospitalization in OOO “Onkoklinika” you should go to the clinic residence (oncology clinic) at the place of your and take a reference (057-U) with the signature of your treating doctor and the seal of the medical organization.
The manager contacts patients just after the concilium of doctors (every Thursday) where the specialists look through all the documents and make a decision about the necessary treatment.